
Sign up to save your podcasts
Or


Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Hope S Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center discuss treatment decision-making for HR-positive metastatic breast cancer in patients who harbor PI3K/AKT/PTEN pathway mutations, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Hope S Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center discuss treatment decision-making for HR-positive metastatic breast cancer in patients who harbor PI3K/AKT/PTEN pathway mutations, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.

142 Listeners

321 Listeners

499 Listeners

67 Listeners

32 Listeners

75 Listeners

15 Listeners

17 Listeners

13 Listeners

0 Listeners

118 Listeners

58 Listeners

3,360 Listeners

198 Listeners

43 Listeners

22 Listeners

363 Listeners

190 Listeners

41 Listeners

0 Listeners